CCL2, C-C motif chemokine ligand 2, 6347

N. diseases: 1157; N. variants: 8
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0014175
Disease: Endometriosis
Endometriosis
0.100 Biomarker disease BEFREE Estrogen receptor β upregulates CCL2 via NF-κB signaling in endometriotic stromal cells and recruits macrophages to promote the pathogenesis of endometriosis. 30838396 2019
CUI: C0014175
Disease: Endometriosis
Endometriosis
0.100 Biomarker disease BEFREE Interleukin-22 and CCL2 secretion by eESCs stimulated by NK cells contributes to the induction of macrophage recruitment and is thus implicated in the development of endometriosis. 31295376 2019
CUI: C0014175
Disease: Endometriosis
Endometriosis
0.100 AlteredExpression disease BEFREE This study investigated the effect of pre-operative oral simvastatin administration on MCP-1 gene expression and serum MCP-1 protein levels in patients with endometriosis. 28950844 2017
CUI: C0014175
Disease: Endometriosis
Endometriosis
0.100 Biomarker disease BEFREE Concentrations of SCGF-β, IL-8, HGF, and MCP-1 were significantly higher, while IL-13 was significantly lower in the endometriosis group compared with the group without endometriosis. 28433374 2017
CUI: C0014175
Disease: Endometriosis
Endometriosis
0.100 AlteredExpression disease BEFREE ESC from endometrial biopsies of six subjects with histologically confirmed endometriosis were treated for 6 h with medium alone or with TNF-α (10 or 100 ng/ml) in the presence of dienogest (DNG), medroxyprogesterone acetate (MPA) and norethisterone acetate (NETA) 10-5 M. The progestin-mediated change in IL6, IL8 and MCP-1 mRNA transcription was measured, as was the PRA, PRB, GR, AR and MCR protein expression. 28412861 2017
CUI: C0014175
Disease: Endometriosis
Endometriosis
0.100 Biomarker disease BEFREE Levels of TFF3 in PF of women with endometriosis were significantly increased ( P < .05) and correlated with local levels of known biomarkers for endometriosis: cancer antigen (CA) 125, CA-19-9, interleukin 8, monocyte chemotactic protein 1, and matrix metalloproteinase 7. 27330011 2017
CUI: C0014175
Disease: Endometriosis
Endometriosis
0.100 Biomarker disease BEFREE These results suggest a reciprocal activation of macrophages and endometriotic cells via the soluble factors CCL2 and IL6, which may contribute to the development of endometriosis. 29036448 2017
CUI: C0014175
Disease: Endometriosis
Endometriosis
0.100 AlteredExpression disease BEFREE Nonetheless, interferon (IFN)-γ, Interleukin (IL)-10 and monocyte chemoattractant protein-1 (MCP-1) levels were higher in the supernatant of E-MenSCs-PBMC co-cultures. 24939730 2014
CUI: C0014175
Disease: Endometriosis
Endometriosis
0.100 AlteredExpression disease BEFREE Statins inhibit monocyte chemotactic protein 1 expression in endometriosis. 22267540 2012
CUI: C0014175
Disease: Endometriosis
Endometriosis
0.100 AlteredExpression disease BEFREE Our study has demonstrated for the first time that the abnormal lower CD82 expression in ESCs induced by TCDD and estrogen may be an important molecular basis of endometriosis pathogenesis through enhancing the CCL2 secretion and CCR2 expression and the invasion of ESCs via MAPK and integrinβ1 signal pathway. 21685244 2011
CUI: C0014175
Disease: Endometriosis
Endometriosis
0.100 AlteredExpression disease BEFREE However, we observed that the sex steroid treatment stimulated MCP-1 mRNA and protein expression in HEECs from women with endometriosis (P < .05). 19933497 2010
CUI: C0014175
Disease: Endometriosis
Endometriosis
0.100 Biomarker disease LHGDN Proliferative phase samples showed higher epithelial IL-8 and MCP-1 expressions in eutopic endometrium of women with endometriosis compared with that of normal women. 18314120 2009
CUI: C0014175
Disease: Endometriosis
Endometriosis
0.100 AlteredExpression disease LHGDN Three cytokines were significantly higher in the serum of subjects with endometriosis than in the control group: interleukin-6 (IL-6) [4.41 pg/ml (range: 1.47-15.01) versus 0.97 pg/ml (range: 0.29-2.98), respectively; p<0.001], monocyte chemotactic protein-1 (MCP-1) [37.91 pg/ml (range: 24.54-94.74) versus 22.13 pg/ml (range: 13.85-39.45), respectively; p<0.001], and interferon-gamma (INF-gamma) [19.01 pg/ml (range: 1.19-73.52) versus 0.30 pg/ml (range: 0.00-13.05), respectively; p<0.001]. 17582674 2008
CUI: C0014175
Disease: Endometriosis
Endometriosis
0.100 AlteredExpression disease BEFREE During menstrual phase, increased endometrial mRNA levels of alpha(V) integrin, combined alpha(V)beta(3) integrins, and increased peritoneal IL-1 beta mRNA levels--but decreased peritoneal MCP-1 mRNA levels--were observed in women with endometriosis compared with control subjects. 17678915 2008
CUI: C0014175
Disease: Endometriosis
Endometriosis
0.100 Biomarker disease LHGDN Panel of markers can accurately predict endometriosis in a subset of patients. 17706208 2008
CUI: C0014175
Disease: Endometriosis
Endometriosis
0.100 AlteredExpression disease LHGDN In contrast, the percentages of CD14+ cells producing TNF-alpha, IL-6, IL-10, MCP-1, and IL-8 were significantly higher in PB than PF of women with endometriosis. 17207568 2008
CUI: C0014175
Disease: Endometriosis
Endometriosis
0.100 AlteredExpression disease BEFREE This method showed a sensitivity of 92.2%, a specificity of 81.6%, a negative predictive value of 83.3%, a positive predictive value of 92.3%, a likelihood ratio of a positive test result of 5.017, and a likelihood ratio of a negative test result of 0.096 to predict the presence or absence of endometriosis.The results imply the potential use of CCR1 mRNA, MCP-1, and CA125 protein measurements for the diagnosis or exclusion of endometriosis. 19050323 2008
CUI: C0014175
Disease: Endometriosis
Endometriosis
0.100 AlteredExpression disease BEFREE We hypothesize that increased levels of CCL2 in the endometriotic environment may upregulate FASLG expression in human endometrial stromal cells and induce a local immunotolerance in endometriosis. 16687653 2006
CUI: C0014175
Disease: Endometriosis
Endometriosis
0.100 Biomarker disease BEFREE Among various chemokines, regulated-on-activation, normal-T-cell-expressed and -secreted (RANTES) and monocyte chemotactic protein 1 (MCP-1) concentrations have been shown to be increased in the peritoneal fluid of women with endometriosis. 14981141 2004
CUI: C0014175
Disease: Endometriosis
Endometriosis
0.100 AlteredExpression disease LHGDN ELISA was used to measure MCP-1 in the culture supernatants exposed to oxidized LDL and peritoneal fluid from control and endometriosis patients. 12372466 2002
CUI: C0014175
Disease: Endometriosis
Endometriosis
0.100 AlteredExpression disease LHGDN Peritoneal macrophages of women with endometriosis demonstrated an increased capacity to secrete MCP-1 either spontaneously or after stimulation with lipopolysaccharide. 12009356 2002
CUI: C0014175
Disease: Endometriosis
Endometriosis
0.100 Biomarker disease BEFREE The serum of women with endometriosis induced higher secretion of MCP-1 by U937 cells than that of control women, particularly in the initial stages of endometriosis (stages I-II), and recombinant IL-1RII (rIL-1RII) significantly blocked that secretion. 12372465 2002
CUI: C0014175
Disease: Endometriosis
Endometriosis
0.100 Biomarker disease BEFREE These findings suggest that MCP-1 may be involved in the histogenesis and early development of peritoneal endometriosis. 11213838 2001
CUI: C0014175
Disease: Endometriosis
Endometriosis
0.100 AlteredExpression disease BEFREE Effect of hormonal agents on monocyte chemotactic protein-1 expression by endometrial epithelial cells of women with endometriosis. 11056242 2000
CUI: C0014175
Disease: Endometriosis
Endometriosis
0.100 AlteredExpression disease BEFREE Ovarian hormones modulate monocyte chemotactic protein-1 expression in endometrial cells of women with endometriosis. 10871649 2000